Clarus
CRYPTOCOCCAL ANTIGEN Enzyme Immunoassay
Cryptococcal meningitis is one of the most common opportunistic infections among HIV/AIDS patients, estimating more than 220,000 cases and 181,000 deaths worldwide each year.1 Early detection and treatment of infection are key to reducing the mortality associated with this disease.
This test is a direct immunoenzymatic, sandwich microplate assay and has been considered the most sensitive and specific EIA for the detection of cryptococcal antigen.
1) Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873-881.
Specimen Types & Registrations
- CE: Serum & CSF
- FDA: Serum & CSF
Product Reference & Storage Conditions
- CRY101
- 2-8°c
Detect Early. Treat Fast. Save Lives.
Features & Benefits
Results in just 2 Hours
Highly SENSITIVE & SPECIFIC
Test MORE OFTEN
Clinical RelevancyClinical Relevancy 2
